Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Multiple Myeloma

fluorodeoxyglucose f18 has been researched along with Multiple Myeloma in 261 studies

Research

Studies (261)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (0.77)	18.2507
2000's	35 (13.41)	29.6817
2010's	133 (50.96)	24.3611
2020's	91 (34.87)	2.80

Authors

Authors	Studies
Itti, E	1
Ahn, JS; Ahn, SY; Baek, DW; Cho, HJ; Chung, YK; Hong, CM; Jeong, SY; Jung, SH; Kim, HJ; Kim, JH; Lee, J; Lee, JJ; Min, JJ; Moon, JH; Sohn, SK; Song, GY; Yang, DH	1
Detappe, A; Ghoroghchian, PP; Lux, F; Mathieu, C; Mittelheisser, V; Moreno-Gaona, P; Pivot, X; Thomas, E; Tillement, O	1
Wu, F	1
Bastidas, JF; Bronte, A; García-Velloso, MJ; Lozano, MD; Rodriguez, P; Rosales, JJ	1
Baranes, L; Belhadj, K; Blanc-Durand, P; Burns, R; Haioun, C; Itti, E; Le Bras, F; Luciani, A; Mulé, S; Tofighi, M; Zerbib, P	1
Alapat, D; Baker, D; Bimali, M; Carrillo, L; Erra, A; Gundarlapalli, S; Hoque, MS; Kottarathara, M; Mathur, P; Mitma, AA; Ogunsesan, Y; Parikh, R; Sachedina, A; Schinke, C; Thanendrarajan, S; Tricot, G; Van Rhee, F; Yarlagadda, L; Zangari, M	1
Bae, SH; Cho, HJ; Hong, CM; Jeong, SY; Jo, JC; Jung, SH; Kim, DJ; Kim, DY; Kim, HJ; Kim, K; Lee, HS; Lee, JJ; Lee, YJ; Min, CK; Min, JJ; Moon, JH; Mun, YC; Park, SS; Shin, HJ; Sohn, SK; Yi, JH; Yoon, SE	1
Dimitrakopoulou-Strauss, A; Goldschmidt, H; Sachpekidis, C	2
An, C; Liu, Y; Ma, L; Wang, Y; Zhang, W	1
Cao, X; Li, J; Luo, Y; Pan, Q	1
Alberge, JB; Avet-Loiseau, H; Bailly, C; Béné, MC; Bodet-Milin, C; Caillon, H; Carlier, T; Chérel, M; Corre, J; Jamet, B; Kampfenkel, T; Kraeber-Bodéré, F; Magrangeas, F; Minvielle, S; Moreau, P; Sonneveld, P; Touzeau, C; van Duin, M; Wuilleme, S	1
Kang, BS; Kim, M; Lee, YJ; Park, SH; Seo, M	1
Liu, X; Ni, M; Pan, B; Wang, SC; Xie, JK; Xie, Q; Zhan, FL; Zhang, YF	1
Cui, R; Ding, J; Huo, L; Luo, Y	1
Binder, M; Broski, SM; Buadi, F; Charalampous, C; Dingli, D; Dispenzieri, A; Fonder, A; Gertz, MA; Goel, U; Gonsalves, WI; Hayman, SR; Hobbs, M; Hwa, L; Kapoor, P; Kourelis, TV; Kumar, SK; Kyle, RA; Lacy, MQ; Leung, N; Lin, Y; Rajkumar, SV; Warsame, R	1
Antke, C; Antoch, G; Boquoi, A; Fenk, R; Haas, R; Kondakci, M; Lopez Y Niedenhoff, D; Mamlins, E; Mohring, A; Müller, HW; Sawicki, LM; Zukovs, R	1
Matsue, K; Terao, T	1
Deng, C; Han, D; Li, D; Lv, Z; Zhang, X	1
Gülbahar Ateş, S; Uçmak, G	1
Alavi, A; Hemrom, A; Kumar, R; Tupalli, A	1
Cinel, L; Erdil, TY; Kesim, S; Oksuzoglu, K; Ones, T; Ozguven, S	1
Alaskar, AS; Alhejazi, AY; Aljohani, SA; Almuthri, SA; Alruwaili, A; Alsalman, MJ; Gmati, GE; Mendoza, MAC; Numani, SP; Ozair, NM; Saib, IH; Syed, GS; Vishwakarm, RK	1
Akdogan, E; Bulbul, O; Goksel, S; Ilkkilic, K	1
Alonso, R; Gómez, EJ; Gómez-Grande, A; Martínez-López, J; Milara, E; Sánchez-González, P; Seiffert, AP; Tomás-Soler, S	1
Ferrari, C; Granata, V; Maggialetti, N; Minoia, C; Moschetta, M; Nappi, AG; Pisani, AR; Rubini, D; Rubini, G; Stabile Ianora Amato, A	1
Barla, C; Binstok, Y; Cavani, M; Frachia, F; Fregeiro, MS; Lissarrague, E; Ranero, S; Riva, E; Servente, L	1
Avet-Loiseau, H; Bailly, C; Belhadj, K; Béné, MC; Bodet-Milin, C; Caillot, D; De Boer, C; De Keizer, B; Facon, T; Hulin, C; Itti, E; Jamet, B; Kampfenkel, T; Karlin, L; Kraeber-Bodéré, F; Lambert, J; Leleu, X; Levin, MD; Minnema, MC; Moreau, P; Pei, L; Perrot, A; Rigat, F; Sonneveld, P; Vermeulen, J; Zweegman, S	1
Bando, K; Ikeda, S; Iura, A; Kakuta, R; Kano, Y; Kirimura, S; Mori, T; Nagao, T; Nogami, A; Tanaka, Y	1
Arangio Febbo, M; Barilà, G; Cabrelle, G; Campi, C; Cecchin, D; Crimì, F; Lacognata, C; Pavan, L; Semenzato, G; Vedovato, S; Zambello, R; Zanon, C; Zucchetta, P	1
Dapunt, U; Dimitrakopoulou-Strauss, A; Goldschmidt, H; Sachpekidis, C; Strauss, D	1
Ambrosini, V; Bezzi, D; Nanni, C	1
Groen, RJW; Raijmakers, PG; Regelink, JC; Zweegman, S; Zwezerijnen, GJC	1
Lai, AYT; Lo, SSW; Mo, CKM; Wong, TS; Wong, WWC	1
Cao, G; Gai, Y; Hu, Y; Lan, X; Li, J; Qin, C; Sun, C; Sun, X; Xu, X; Zhang, X	1
Liu, W; Ou, X; Yao, X	1
Bodet-Milin, C; Jamet, B; Kraeber-Bodéré, F; Moreau, P; Touzeau, C	1
Cho, YS; Choi, JY; Hyun, SH; Kim, K; Lee, H; Lee, KH; Moon, SH	2
Chakraborty, R; Hillengass, J; Lentzsch, S	1
Gupta, R; Kumar, L; Kumar, R; Mookerjee, A; Pandey, RM; Sharma, A	1
Chen, X; Chen, Y; Huang, C; Huang, D; Wu, J; Zhong, H	1
Zirakchian Zadeh, M	1
Das, S; Iqbal, S; Kapoor, R; Yanamandra, U	1
Catalano, L; Del Vecchio, S; Fonti, R; Pace, L; Pane, F; Pellegrino, S	1
Berckmans, M; Boyadzhiev, D; Collette, L; Jamar, F; Lecouvet, FE; Michoux, N; Pasoglou, V; Triqueneaux, P; Vekemans, MC	1
Chen, T; Schlicht, S; Taubman, K; Xiao, H; Yap, K	1
Abildgaard, N; Alavi, A; Gerke, O; Holdgaard, P; Høilund-Carlsen, PF; Khosravi, M; Kim, J; Nielsen, AL; Pourhassan Shamchi, S; Raynor, WY; Revheim, ME; Taghvaei, R; Werner, TJ; Zirakchian Zadeh, M; Østergaard, B	1
Brunetto, SQ; de Souza, C; Lorand-Metze, I; Mosci, C; Pericole, FV; Ramos, CD; Souza, EM; Takahashi, MES	1
An, C; Geng, H; Wang, P; Zhai, L; Zhang, W	1
Araz, M; Beksaç, M; Cengiz Seval, G; Nak, D; Özkan, E	1
Chen, JW; Huang, WS; Xu, JH; Zhang, GX; Zheng, Y	1
Adam, Z; Brozova, L; Koukalova, R; Kral, Z; Krejci, M; Mayer, J; Pour, L; Rehak, Z; Sandecka, V; Sevcikova, S; Stork, M	1
Aslanidi, IP; Firsova, MV; Mendeleeva, LP; Mukhortova, OV; Savchenko, VG; Solovev, MV	1
Amini, B; Boutin, RD; Lenchik, L; Manasanch, EE; Nakache, YN; Nardo, L; Sun, J	1
Akin, O; Causa Andrieu, PI; Das, JP; Ryan, R; Ulaner, GA; Woo, S	1
Amorim, BJ; Carvalheira, JBC; de Souza, CA; Delamain, MT; Etchebehere, ECSC; Lima, MCL; Lorand-Metze, I; Miranda, ECM; Mosci, C; Oliveira, GB; Pericole, FV; Ramos, CD; Santos, AO; Takahashi, MES	1
Bailly, C; Bodet-Milin, C; Carlier, T; Jamet, B; Kraeber-Bodere, F; Michaud, AV; Moreau, P; Nanni, C; Touzeau, C; Zamagni, E	1
Garderet, L; Martino, S; Montravers, F; Talbot, JN; Zhang-Yin, J	1
Diao, W; Jia, Z; Zhao, C; Zhong, X	1
Han, S; Kim, YI; Ryu, JS; Woo, S; Yoon, DH	1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J	1
Bas, V; Baysal, M; Demirci, U; Durmus Altun, G; Karaman Gulsaran, S; Korkmaz, U; Muzaffer Demir, A; Onur Kirkizlar, H; Umit, EG	1
Graham, MM; Pillenahalli Maheshwarappa, R	1
Choyke, P; Dew, A; Hill, E; Kazandjian, D; Lindenberg, L; Mena, E; Morrison, C	1
Bailly, C; Bodet-Milin, C; Carlier, T; Chauvie, S; Jamet, B; Kraeber-Bodéré, F; Mateus, D; Michaud, AV; Moreau, P; Morvan, L; Nanni, C; Touzeau, C; Zamagni, E	1
Carnahan, MB; Conley, CR; Larsen, JT; Yang, M	1
Chatzipavlidou, V; Katodritou, E; Konstantinidou, P; Markala, D; Palaska, V; Panagiotidis, E; Papanikolaou, A; Paschali, A; Pouli, A; Terpos, E; Triantafyllou, T; Tsirou, K; Verrou, E; Υiannaki, E	1
Alavi, A; Taghvaei, R; Werner, TJ; Zadeh, MZ	1
Bailly, C; Barbato, S; Boccadoro, M; Bodet-Milin, C; Caillot, D; Carlier, T; Cavo, M; Chauvie, S; Dozza, L; Fanti, S; Gallamini, A; Gamberi, B; Garderet, L; Gay, F; Karlin, L; Kraeber-Bodéré, F; Macro, M; Moreau, P; Nanni, C; Patriarca, F; Perrot, A; Sonneveld, P; Tacchetti, P; Versari, A; Zamagni, E	1
Araz, M; Beksaç, M; Cengiz Seval, G; Küçük, NÖ; Özkan, E	1
Borggrefe, J; Fervers, P; Gertz, R; Glauner, A; Kottlors, J; Maintz, D; Täger, P	1
Benz, DC; Buechel, RR; Dorbala, S	1
Amlani, A; Bailey, K; Bassett, P; Cook, GJR; El-Najjar, I; Fraczek, M; Gleeson, M; Goh, V; Kelly-Morland, C; Streetly, M; Westerland, O	1
Ahn, JS; Ahn, SY; Baek, DW; Bom, HS; Cho, HJ; Hong, CM; Jeong, SY; Jung, SH; Kang, SR; Kim, HJ; Lee, JJ; Min, JJ; Moon, JH; Park, HK; Sohn, SK; Song, GY; Yang, DH	1
Kuzume, A; Machida, Y; Matsue, K; Miura, D; Narita, K; Tabata, R; Takeuchi, M; Tateishi, U; Terao, T; Tsushima, T	1
Calice, G; Gallicchio, R; Guarini, A; Guglielmi, G; Nardelli, A; Storto, G	1
Aguado Bueno, B; Alegre, A; Carreras, JL; Colletti, PM; Delgado Bolton, RC; Gómez León, N; Herreros Pérez, M; León Ramírez, LF; Rubello, D	1
Brambilla, SR; Carvalheira, JBC; da Cunha, AD; de Souza, EM; Mendes, MCS; Mosci, C; Pericole, FV; Prado, CM; Ramos, CD; Silveira, MN; Takahashi, MES	1
Fan, Q; Su, M; Wang, Y	1
Brambilla, SR; Carvalheira, JBC; da Cunha Júnior, AD; de Souza, EM; Mendes, MCS; Mosci, C; Pericole, FV; Prado, CM; Ramos, CD; Silveira, MN; Takahashi, MES	1
Bredella, MA; Vicentini, JRT	1
Baghal, A; Eichhorn, J; Haq, I; Wang, X	1
Bernard, S; Fayad, LM; Ilaslan, H; Messiou, C; Moulopoulos, LA; Mulligan, ME; Wu, F	1
Broccoli, A; Calabrò, D; Fanti, S; Mattana, F; Nanni, C; Paccagnella, A; Zanoni, L	1
Hirata, K; Kuzume, A; Machida, Y; Matsue, K; Miura, D; Narita, K; Tabata, R; Takeuchi, M; Tateishi, U; Terao, T; Tsushima, T	1
Broski, SM; Buadi, FK; Dingli, D; Dispenzieri, A; Fonder, A; Gertz, MA; Go, RS; Gonsalves, W; Hayman, S; Hobbs, M; Hwa, L; Kaddoura, M; Kapoor, P; Kourelis, T; Kumar, S; Kyle, RA; Lacy, MQ; Leung, N; Lin, Y; Lust, J; Rajkumar, V; Warsame, R	1
O'Donnell, EK; Shapiro, YN	1
Acid, S; Gheysens, O; Hillengass, J; Jamar, F; Kirchgesner, T; Lecouvet, FE; Malghem, J; Van Den Berghe, T; Vande Berg, BC; Vandecaveye, V; Vekemans, MC; Verstraete, K; Wuts, J	1
Boyer, A; Jahnwar, YS; Lane, JM; Marty, E; Niesvizky, R; Or, O; Saiyed, R	1
Li, J; Liu, P; Shi, H; Tan, H; Xu, T	1
Chae, EJ; Chung, HW; Kim, KW; Ko, Y; Lee, JH; Lee, K; Park, HY; Ryu, JS	1
Shen, Y; Zhang, D; Zhu, D; Zhu, X; Zou, S	1
Angtuaco, E; Barlogie, B; Buros, A; Davies, FE; Epstein, J; Goldschmidt, H; Hemminki, K; Houlston, R; McDonald, JE; Meissner, T; Morgan, GJ; Pawlyn, C; Rasche, L; Samant, R; Schinke, C; Stein, C; Thanendrarajan, S; van Rhee, F; Walker, BA; Weinhold, N; Yaccoby, S; Zangari, M	1
Fukunaga, H; Miyazawa, H; Mutoh, T; Shimomura, H; Taki, Y; Tatewaki, Y; Terao, C; Totsune, T	1
Ou, X; Ye, Y; Zhong, X	1
Barrington, S; Chantry, A; Goh, V; Kazmi, M; Lai, M; Mulholland, N; Pratt, G; Streetly, M	1
Anderson, K; Attal, M; Avet-Loiseau, H; Benboubker, L; Bodet-Milin, C; Caillon, F; Caillot, D; Chaleteix, C; Dorvaux, V; Dupas, B; Escoffre-Barbe, M; Eveillard, JR; Facon, T; Frampas, E; Garderet, L; Gaultier, A; Hulin, C; Karlin, L; Kraeber-Bodere, F; Laribi, K; Macro, M; Marit, G; Moreau, P; Munshi, NC; Nguyen, JM; Pegourie, B; Perrot, A; Richardson, P; Stoppa, AM	1
Kai, K; Kimura, S; Kojima, K; Kusaba, K; Naito, S; Nishida, Y; Taba, M; Ureshino, H	1
Choe, S; Duan, X; He, Y; Huang, T; Lan, X; Li, C; Sattar, H; Tu, H; Zhou, F	1
Bellò, M; Bertone, E; Bianchi, A; Cavo, M; Chauvie, S; Fanti, S; Gallamini, A; Gamberi, B; Gay, F; Ghedini, P; Nanni, C; Patriarca, F; Rensi, M; Versari, A; Zamagni, E	1
Barlogie, B; Davies, FE; Hoering, A; McDonald, JE; Morgan, GJ; Ntambi, JA; Panozzo, SB; Petty, NM; Rasche, L; Rosenthal, A; Schinke, CD; Steward, DM; Thanendrarajan, S; van Rhee, F; Walker, B; Weinhold, N; Zangari, M	1
Bailly, C; Bodet-Milin, C; Carlier, T; Jamet, B; Kraeber-Bodéré, F; Moreau, P; Planche, L; Touzeau, C	1
Arda, HÜ; Bolaman, AZ; Cengiz, A; Döğer, F; Yavaşoğlu, İ; Yürekli, Y	1
Agrawal, A; Choudhury, S; Purandare, N; Rangarajan, V; Shah, S	1
Caldarella, C; De Stefano, V; Giordano, A; Pizzuto, DA; Ripani, D; Rossi, E; Za, T	1
Attal, M; Bailly, C; Bodet-Milin, C; Caillot, D; Carlier, T; Eugene, T; Facon, T; Garderet, L; Hulin, C; Jamet, B; Kraeber-Bodéré, F; Leleu, X; Macro, M; Moreau, P; Perrot, A; Touzeau, C	1
Amlal, S; Bahloul, A; Marie, PY; Perrin, M; Verger, A	1
Deng, S; Li, J; Sang, S; Xu, X; Zhang, B; Zhang, W; Zhou, Y	1
Aljama, MA; Buadi, FK; Dingli, D; Dispenzieri, A; Fonder, AL; Gertz, MA; Go, RS; Gonsalves, WI; Hayman, SR; Hobbs, MA; Hwa, YL; Kapoor, P; Kourelis, T; Kumar, SK; Kyle, RA; Lacy, MQ; Leung, N; Muchtar, E; Rajkumar, SV; Sidiqi, MH; Warsame, RM	1
Basques, K; Behzadi, AH; Carrino, JA; Gholamrezanezhad, A; Jadvar, H; Kosmas, C; Matcuk, GR; Patel, J; Raza, SI	1
Chen, X; Fu, Z; Li, Q; Yang, X	1
Amiras, D; Barwick, T; Bretsztajn, L; Messiou, C; Rockall, A; Wallitt, K	1
Abe, Y; Kitadate, A; Kobayashi, H; Matsue, K; Miura, D; Narita, K; O'uchi, E; O'uchi, T; Takeuchi, M	1
Gopalakrishnan, SK; Liang, HH; Velaga, J	1
Dimitrakopoulou-Strauss, A; Goldschmidt, H; Hillengass, J; Jauch, A; Kopp-Schneider, A; Merz, M; Raab, MS; Sachpekidis, C; Sauer, S	1
Bailly, C; Bodet-Milin, C; Carlier, T; Jamet, B; Kraeber-Bodéré, F; Moreau, P; Touzeau, C	1
Mahindra, A; Pham, A	1
Abe, Y; Ikeda, S; Kitadate, A; Kobayashi, H; Matsue, K; Miura, D; Narita, K; O'uchi, E; O'uchi, T; Takeuchi, M	1
Alavi, A; Ayubcha, C; Kothekar, E; Raynor, WY; Seraj, SM; Werner, T; Zadeh, MZ	1
Beksac, M; Ozkan, E; Seval, GC	1
Nanni, C; Zamagni, E	1
Broski, SM; Glazebrook, KN; Kumar, S	1
Cao, Z; Chen, L; Fan, F; Gao, S; Li, D; Li, H; Li, Q; Liu, S; Ma, J; Wang, X; Wang, Y; Xu, W; Yan, T; Yang, H; Yu, Y; Yue, Y; Zhang, Y; Zhao, H; Zhao, Z	1
Jia, Z; Su, M; Zhong, X	1
Bailly, C; Bodet-Milin, C; Carlier, T; Jamet, B; Kraeber-Bodéré, F; Mateus, D; Moreau, P; Morvan, L	1
Lu, Y	1
Lan, X; Li, C; Shao, F; Yang, Y	1
An, CH; An, SY; Choi, KS; Heo, MS	1
Agarwal, A; Chirindel, A; Shah, BA; Subramaniam, RM	1
Gandhi, N; Safar, B; Thupili, C	1
de Keizer, B; Minnema, MC	1
Cascini, GL; Console, D; Falcone, C; Parlati, A; Restuccia, A; Rossi, M; Tamburrini, O	1
Peller, PJ	2
Liu, F; Pastakia, B; Xu, F	1
Chang, WJ; Choi, JY; Choi, MK; Hong, JY; Jang, JH; Jung, CW; Kim, K; Kim, SJ; Kim, WS; Kim, YS; Lee, SJ; Maeng, CH; Park, S	1
Buck, AK; Einsele, H; Jörg, G; Knop, S; Lapa, C; Lückerath, K; Rosenwald, A; Samnick, S; Spahmann, A	1
Nakamoto, Y	1
Cavo, M; Fanti, S; Mancuso, K; Marzocchi, G; Nanni, C; Pantani, L; Pezzi, A; Rocchi, S; Tacchetti, P; Terragna, C; Testoni, N; Zamagni, E; Zannetti, B	1
Cheng, C; Dimitrakopoulou-Strauss, A; Goldschmidt, H; Haberkorn, U; Hose, D; Kopka, K; Pan, L; Sachpekidis, C	1
Adam, T; Bacovsky, J; Bartkova, M; Gronowitz, SJ; Minarik, J; Myslivecek, M; Petrova, P; Pika, T; Scudla, V; Zapletalova, J	1
Chen, S; Cheng, T; Cheung, SK; Chim, CS; Ho, CL; Leung, YL; Liang, R; Wong, KN	1
Adib, S; Beauvais, D; Berthon, C; Bonnet, S; Coiteux, V; Decaux, O; Demarquette, H; Facon, T; Fouquet, G; Guidez, S; Herbaux, C; Hivert, B; Huglo, D; Leleu, X; Macro, M; Terriou, L; Van de Wyngaert, Z; Wemeau, M	1
Choi, YY; Kim, JY; Yang, SO	1
Knop, S; Lapa, C; Lückerath, K	1
Dimitrakopoulou-Strauss, A	1
Kimura, S; Kubota, Y; Matsuzaki, M	1
Dammacco, F; Ferrari, C; Racanelli, V; Rubini, G; Vacca, A	1
Buck, AK; Einsele, H; Herrmann, K; Knop, S; Lapa, C; Lückerath, K; Malzahn, U; Samnick, S	1
Chari, A; Fardanesh, R; Jagannath, S; Kostakoglu, L; Mesguich, C; Tanenbaum, L	1
Hagiwara, S; Hirai, R; Inoue, T; Ishiwata, K; Ito, K; Kubota, K; Minamimoto, R; Miwa, A; Miyata, Y; Morooka, M; Okasaki, M; Toyohara, J	1
Goldsmith, SJ; Mihailovic, J	1
Dong, MJ; Liu, NH; Weng, WW; Xu, Q; Yang, J; Zhang, J; Zhu, YJ	1
de Waal, EG; Kluin, PM; Leene, MJ; Slart, RH; Vellenga, E	1
Catalano, L; Cerchione, C; De Luca, S; Del Vecchio, S; Fonti, R; Pace, L; Pane, F; Salvatore, B; Salvatore, M	1
Kobayashi, M; Takaori-Kondo, A; Yamashita, K	1
Bruno, B; Buttignol, S; Carobolante, F; Cavo, M; Corradini, P; Englaro, E; Fanin, R; Geatti, O; Isola, M; Montefusco, V; Nanni, C; Patriarca, F; Sperotto, A; Stocchi, R; Zamagni, E	1
Dimitrakopoulou-Strauss, A; Goldschmidt, H; Haberkorn, U; Hillengass, J; Hose, D; Mai, EK; Pan, L; Sachpekidis, C	1
Bryanton, M; Makis, W	1
Ak, İ; Akay, OM; Onner, H	1
Borsi, E; Brioli, A; Cavo, M; Fanti, S; Mancuso, K; Martello, M; Marzocchi, G; Nanni, C; Pantani, L; Pezzi, A; Rambaldi, I; Rizzello, I; Rocchi, S; Tacchetti, P; Terragna, C; Zamagni, E; Zannetti, B	1
Comert, M; Ömür, Ö; Oral, A; Saydam, G; Yazici, B	1
Jacene, H; Munshi, NC; Ramaiya, NH; Sakellis, C; Shinagare, AB; Tirumani, SH; Van den Abbeele, AD	1
Guan, LL; Li, JQ; Lv, ZX; Pang, H; Wang, J; Xu, YH	1
Alberich-Bayarri, Á; Martí-Bonmatí, L; Ramirez-Fuentes, C; Ruiz-Llorca, C	1
Cha, HJ; Choi, Y; Jo, JC; Kim, H; Lim, JH; Park, SH; Seo, M	1
Bellò, M; Bianchi, A; Cavo, M; Chauvie, S; Fanti, S; Gallamini, A; Gamberi, B; Gay, F; Nanni, C; Patriarca, F; Rambaldi, I; Rensi, M; Versari, A; Zamagni, E	1
Balma, M; Bellò, M; Carobolante, F; Cavo, M; Chauviè, S; Dimitrakopoulou-Strauss, A; Fanti, S; Fard, N; Gamberi, B; Gay, F; Ghedini, P; Hillengass, J; Magarotto, V; Mancuso, K; Marzocchi, G; Musto, P; Nanni, C; Offidani, M; Palumbo, A; Pantani, L; Patriarca, F; Pezzi, A; Rambaldi, I; Rensi, M; Rocchi, S; Storto, G; Tacchetti, P; Versari, A; Zamagni, E; Zannetti, B	1
Cheng, A; Liping, F; Wang, X; Yang, J; Zhao, L	1
Bluemel, C; Buck, AK; Einsele, H; Hänscheid, H; Herrmann, K; Keller, U; Knop, S; Knott, M; Kropf, S; Lapa, C; Lassmann, M; Lückerath, K; Osl, T; Poschenrieder, A; Samnick, S; Schirbel, A; Schottelius, M; Schreder, M; Wester, HJ	1
Bhutani, M; Calvo, KR; Carpenter, A; Choyke, PL; Korde, N; Kurdziel, K; Kwok, M; Lamping, E; Landgren, O; Lindenberg, L; Mailankody, S; Manasanch, EE; Maric, I; Mena, E; Minter, AR; Mulquin, M; Roschewski, M; Tageja, N; Tan, E; Turkbey, B; Usmani, SZ; Weiss, BM	1
Buck, AK; Einsele, H; Herrmann, K; Jörg, G; Knop, S; Knott, M; Lapa, C; Lückerath, K; Rudelius, M; Samnick, S; Schreder, M	1
Hindié, E; Mesguich, C; Zanotti-Fregonara, P	1
Balogova, S; Calzada, M; Cassou-Mounat, T; Devaux, JY; Garderet, L; Huchet, V; Kerrou, K; Mohty, M; Nataf, V; Talbot, JN	1
Andersen, KT; Hinge, M; Holdgaard, PC; Jørgensen, HB; Lund, T; Ormstrup, TE; Plesner, T; Østergaard, LL	1
Borrego Dorado, I; de Bonilla Damiá, A; Fernández López, R; Paz Coll, A	1
Akers, WJ; Cenci, S; Civitelli, R; D'avignon, A; Fontana, F; Ge, X; Hathi, D; Shoghi, KI; Shokeen, M; Su, X; Weilbaecher, KN; Xiang, J	1
Chen, M; Diao, X; Huang, B; Li, J; Li, Y; Liu, J	1
Eluvathingal, T; Fogel, B; Kothari, A; Mohan, M; Schinke, C	1
Akyel, R; Aydin, Y; Demirci, E; Elverdi, T; Erkan, ME; Halac, M; Ocak, M; Sonmezoglu, K; Vatankulu, B	1
Annunziata, S; Caldarella, C; De Stefano, V; Pagano, L; Rufini, V	1
Alam, MS; Fu, L; Han, YJ; Li, HS; Ren, YY; Wang, QS; Wang, Z; Wu, HB; Zhou, WL	1
Fan, C; Liang, M; Su, M; Wang, R; Wang, W	1
Bailly, C; Bodet-Milin, C; Bourgeois, M; Carlier, T; Chérel, M; Guérard, F; Jamet, B; Kraeber-Bodéré, F; Leforestier, R; Moreau, P; Touzeau, C	1
Matsuda, M; Sueda, S; Taniguchi, T	1
Seppanen, M	1
Castellon, I; Cholewinski, W; Heiba, SI; Raphael, B	1
Kimura, S; Matsue, K; Odawara, J; Takeuchi, M; Yamakura, M	1
Baur-Melnyk, A; Delorme, S	2
Breen, KA; Eustace, SJ; Gleeson, TG; McHugh, J; O'Connell, MJ; O'Gorman, PJ; Shortt, CP	1
Alpe, T; Anaissie, E; Angtuaco, E; Barlogie, B; Bartel, TB; Brown, TL; Crowley, J; Epstein, J; Haessler, J; Shaughnessy, JD; van Rhee, F; Walker, R	1
Bergner, R; Dimitrakopoulou-Strauss, A; Haberkorn, U; Hoffmann, M; Strauss, LG; Uppenkamp, M	1
Croockewit, S; de Rooy, JW; Koedam, E; Lütje, S; Oyen, WJ; Raymakers, RA	1
Baldini, L; Calori, R; Carletto, M; Castellani, M; Dellavedova, L; Gerundini, P; Longari, V; Soligo, D	1
Christensen, CR; Crim, JR; Hanrahan, CJ	1
Nguyen, BD; Ram, PC	1
Ishikawa, T; Kitano, T; Nakamoto, Y; Nishizawa, M; Suga, T; Yamashita, K	1
Ginat, DT; Puri, S	1
Ak, I; Gulbas, Z	1
Klarhöfer, M; Lenz, C; Scheffler, K; Sommer, G; Winter, L	1
Bacovský, J; Buriánková, E; Formánek, R; Koranda, P; Minarík, J; Myslivecek, M; Scudla, V; Zapletalová, J	1
Elliott, BM; Isola, L; Kostakoglu, L; Lee, D; Osman, K; Peti, S; Scigliano, E	1
Cermik, TF; Cetin, G; Ciftci, H; Ergül, N; Güner, SI; Sager, S	1
Akdemir, OU; Akı, SZ; Ceneli, O; Haznedar, R; Ozkurt, ZN; Sucak, GT; Unlü, M; Yağcı, M	1
Dimopoulos, MA; Moulopoulos, LA; Terpos, E	1
Chirindel, A; Karchevsky, M; Mulligan, M	1
Abe, S; Hatakeyama, N; Hino, H; Hosokawa, E; Inayama, M; Iwahara, Y; Machida, H; Naruse, K; Ogushi, F; Okano, Y; Shinohara, T; Yoshida, M	1
Hoekstra, OS; Regelink, JC; Riphagen, II; van Lammeren-Venema, D; Zijlstra, JM; Zweegman, S	1
Cheng, X; Cui, R; Li, F; Zhuang, H	1
Baccarani, M; Brioli, A; Buttignol, S; Carobolante, F; Cavo, M; Englaro, E; Fanin, R; Fanti, S; Nanni, C; Pantani, L; Patriarca, F; Perrone, G; Pezzi, A; Tacchetti, P; Terragna, C; Zamagni, E; Zannetti, B	1
Hain, SF; Khan, S; Stevenson, W	1
Kim, SH; Mulligan, ME; Smith, SE	1
Cocciolillo, F; Giordano, A; Treglia, G; Villani, MF	1
Ayuk, F; Derlin, T; Habermann, CR; Herrmann, J; Klutmann, S; Kröger, N; Weber, C; Wisotzki, C; Wolschke, C	1
Moreau, P	1
Adam, G; Bannas, P; Derlin, T; Habermann, CR; Herrmann, J; Kröger, N; Münster, S; Peldschus, K; Stübig, T; Weber, C	1
Chen, JH; Kao, CH; Liang, JA; Lin, WY; Lu, YY; Tsai, SC; Wang, HY	1
Arisaka, Y; Higuchi, T; Isoda, A; Kaira, K; Kamio, T; Matsumoto, M; Mawatari, M; Nakano, S; Sawamura, M; Tsushima, Y	1
Albisinni, U; Battista, G; Bazzocchi, A; Brioli, A; Cavo, M; Fanti, S; Nanni, C; Salizzoni, E; Spinnato, P; Zamagni, E	1
de Waal, EG; Slart, RH; Vellenga, E	1
Catalano, L; De Luca, S; Del Vecchio, S; Fabbricini, R; Fonti, R; Larobina, M; Pace, L; Pane, F; Salvatore, M	1
Torizuka, T	1
Caldarella, C; Isgrò, MA; Treglia, G; Treglia, I	1
Ambrosini, V; Brioli, A; Caroli, P; Cavo, M; Celli, M; Colletti, PM; Fanti, S; Nanni, C; Pantani, L; Perrone, G; Pezzi, A; Rubello, D; Tacchetti, P; Zamagni, E; Zannetti, B; Zompatori, M	1
Bailly, C; Bodet-Milin, C; Dupas, B; Eugène, T; Frampas, E; Kraeber-Bodéré, F; Lacombe, M; Moreau, P	1
Brillet, E; Decaux, O; Duvauferrier, R; Guillin, R; Marchand, A; Niederberger, E; Patrat-Delon, S; Rescan, M; Valence, M	1
Anaissie, E; Barlogie, B; Bartel, T; Brown, T; Crowley, J; Hoering, A; Mitchell, A; Petty, N; Usmani, SZ; van Rhee, F; Waheed, S	1
Moreau, P; Touzeau, C	1
D'Agnolo, A; Durie, BG; Waxman, AD; Williams, CM	1
Conti, PS; Jadvar, H	1
Bar-Shalom, R; Bennett, M; Gavish, I; Israel, O	1
Carrasquillo, JA; Chen, CC; Dunleavy, K; Nguyen, JD	1
Blum, R; Hicks, RJ; Mileshkin, L; Patrikeos, A; Prince, HM; Seymour, JF	1
Meyer, MA	1
Anaissie, EJ; Barlogie, B; Jones Jackson, LB; Miceli, MH; Talamo, G; Walker, RC	1
Bredella, MA; Caputo, G; Hawkins, R; Segall, G; Steinbach, L	1
Anaissie, E; Barlogie, B; Fassas, A; Grazziutti, ML; Jones-Jackson, L; Mahfouz, T; Miceli, MH; Purnell, G; Saghafifar, F; Stroud, S; Tricot, G; Walker, R	1
Cangini, D; Canini, R; Castellucci, P; Cavo, M; Fanti, S; Farsad, M; Nanni, C; Salizzoni, E; Tosi, P; Zamagni, E	1
Belohlávek, O	1
Adam, Z; Bolcák, K; Hájek, R; Krejcí, M; Mareschova, Y; Neubauer, J; Pour, L; Prásek, J; Stanícek, J; Vorlícek, J	1
Badros, AZ; Breyer, RJ; Line, BR; Mulligan, ME; Smith, SE	1
Baccarani, M; Brioli, A; Buttignol, S; Cangini, D; Castellucci, P; Cavo, M; Ceccolini, M; Englaro, E; Fanin, R; Fanti, S; Geatti, O; Nanni, C; Patriarca, F; Perrone, G; Salizzoni, E; Tacchetti, P; Tosi, P; Zamagni, E	1
Califano, C; Caparrotti, G; Catalano, L; Del Vecchio, S; Fonti, R; Martorelli, C; Pace, L; Petruzziello, F; Rotoli, B; Salvatore, B; Segreto, S	1
Abildgaard, N; D'Sa, S; Hall-Craggs, M; Shaw, P; Tighe, J	1
Al-Nahhas, A; Ambrosini, V; Castellucci, P; Cavo, M; Fanti, S; Farsad, M; Franchi, R; Montini, GC; Nanni, C; Pettinato, C; Rubello, D; Tacchetti, P; Zamagni, E	1
Nguyen, BD; Wiesenthal, AA	1
Adam, Z; Bolcak, K; Buchler, T; Hajek, R; Krejci, M; Neubauer, J; Pour, L; Prasek, J; Stanicek, J; Vorlicek, J	1
Chang, A; Cohen, S; Ghesani, M; Goel, S; Maslin, P; Meka, M	1
Catalano, L; Del Vecchio, S; Fonti, R; Liuzzi, R; Pace, L; Petruzziello, F; Quarantelli, M; Rotoli, B; Salvatore, B; Salvatore, M; Segreto, S; Sirignano, C	1
Mulligan, ME	1
Anderson, KC; Chhetri, S; Connell, B; Hande, K; Hideshima, T; Munshi, NC; Raje, N; Richardson, PG; Schlossman, RL; Sheehy, N; Szot-Barnes, A; Tai, YT; Tian, M; Treister, N; Vallet, S; Van Den Abbeele, AD; Weller, E; Woo, SB; Xie, W; Yap, JT	1
Hur, J; Ryu, YH; Suh, JS; Yoon, CS; Yun, MJ	1
Fukumura, T; Ichiya, Y; Kawai, Y; Koga, H; Kuwabara, Y; Masuda, K; Otsuka, M; Sasaki, M	1
el-Shirbiny, AM; Imbriaco, M; Larson, SM; Macapinlac, H; Michaeli, J; Yeung, H	1
Barrington, S; Buscombe, J; Hilson, A; Mehta, A; Orchard, K; Prentice, HG	1
Bergmann, L; Bommer, M; Buck, AK; Bunjes, D; Döhner, H; Messer, P; Müller, S; Reske, SN; Schirrmeister, H	1
Fukumitsu, H; Hoshikawa, T; Ishikawa, K; Makuuchi, H; Nasu, S; Sadahiro, S; Shibuya, M; Shimakura, Y; Suzuki, T; Tajima, T; Yasuda, S; Yazawa, N	1

Reviews

45 review(s) available for fluorodeoxyglucose f18 and Multiple Myeloma

Article	Year
[Positron emission tomography/computed tomography (PET/CT) in multiple myeloma]. Der Radiologe, 2022, Volume: 62, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2022
Progress of modern imaging modalities in multiple myeloma. International journal of hematology, 2022, Volume: 115, Issue:6 Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed	2022
PET clinics, 2022, Volume: 17, Issue:3 Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2022
Clinical Value of FDG-PET/CT in Multiple Myeloma: An Update. Seminars in nuclear medicine, 2023, Volume: 53, Issue:3 Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals	2023
Clinical Application of Clinical lymphoma, myeloma & leukemia, 2023, Volume: 23, Issue:11 Topics: Fluorodeoxyglucose F18; Hematologic Neoplasms; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2023
Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma. Molecules (Basel, Switzerland), 2019, Dec-29, Volume: 25, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Neoplasm Staging; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radioactive Tracers; Radiopharmaceuticals; Treatment Outcome	2019
Functional Imaging for Therapeutic Assessment and Minimal Residual Disease Detection in Multiple Myeloma. International journal of molecular sciences, 2020, Jul-29, Volume: 21, Issue:15 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Diffusion Magnetic Resonance Imaging; Drug Monitoring; Fluorodeoxyglucose F18; Humans; Ligands; Molecular Probes; Multiple Myeloma; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Receptors, CXCR4; Remission Induction; Tomography, X-Ray Computed	2020
Fluorodeoxyglucose-avid focal lesions and extramedullary disease on 18F-FDG PET/computed tomography predict the outcomes of newly diagnosed symptomatic multiple myeloma patients. Nuclear medicine communications, 2020, Volume: 41, Issue:9 Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography	2020
Prognostic value of European radiology, 2021, Volume: 31, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals	2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Role of FDG PET in the staging of multiple myeloma. Skeletal radiology, 2022, Volume: 51, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2022
Updates and Ongoing Challenges in Imaging of Multiple Myeloma: AJR. American journal of roentgenology, 2021, Volume: 217, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed	2021
Overview and recent advances in PET/CT imaging in lymphoma and multiple myeloma. European journal of radiology, 2021, Volume: 141 Topics: Adult; Child; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging	2021
Oncologist perspective: role of imaging in myeloma. Skeletal radiology, 2022, Volume: 51, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Oncologists; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging	2022
Imaging of treatment response and minimal residual disease in multiple myeloma: state of the art WB-MRI and PET/CT. Skeletal radiology, 2022, Volume: 51, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging	2022
Comprehensive Updates in the Role of Imaging for Multiple Myeloma Management Based on Recent International Guidelines. Korean journal of radiology, 2021, Volume: 22, Issue:9 Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging	2021
Applications of PET/CT and PET/MR Imaging in Primary Bone Malignancies. PET clinics, 2018, Volume: 13, Issue:4 Topics: Adult; Aged; Bone Neoplasms; Chondrosarcoma; Female; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Osteosarcoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma, Ewing; Young Adult	2018
Imaging in myeloma with focus on advanced imaging techniques. The British journal of radiology, 2019, Volume: 92, Issue:1095 Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Tomography, X-Ray Computed; Whole Body Imaging	2019
Solitary Plasmacytoma: a Review of Diagnosis and Management. Current hematologic malignancy reports, 2019, Volume: 14, Issue:2 Topics: Bone Neoplasms; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Myeloma Proteins; Plasma Cells; Plasmacytoma; Positron Emission Tomography Computed Tomography	2019
Evolving Roles of Fluorodeoxyglucose and Sodium Fluoride in Assessment of Multiple Myeloma Patients: Introducing a Novel Method of PET Quantification to Overcome Shortcomings of the Existing Approaches. PET clinics, 2019, Volume: 14, Issue:3 Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sodium Fluoride	2019
PET with Fluorodeoxyglucose F 18/Computed Tomography as a Staging Tool in Multiple Myeloma. PET clinics, 2019, Volume: 14, Issue:3 Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2019
Fluorodeoxyglucose-PET/Computed Tomography as a Predictor of Prognosis in Multiple Myeloma. PET clinics, 2019, Volume: 14, Issue:3 Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Treatment Outcome	2019
Fludeoxyglucose F 18 PET/Computed Tomography Evaluation of Therapeutic Response in Multiple Myeloma. PET clinics, 2019, Volume: 14, Issue:3 Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Treatment Outcome	2019
Leveraging RSF and PET images for prognosis of multiple myeloma at diagnosis. International journal of computer assisted radiology and surgery, 2020, Volume: 15, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Machine Learning; Multiple Myeloma; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals	2020
Evolving role of FDG PET/CT in multiple myeloma imaging and management. AJR. American journal of roentgenology, 2013, Volume: 200, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Multiple Myeloma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2013
Role of positron emission tomography/computed tomography in bone malignancies. Radiologic clinics of North America, 2013, Volume: 51, Issue:5 Topics: Biopsy; Bone Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Multiple Myeloma; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity	2013
PET/CT in benign and malignant musculoskeletal tumors and tumor-like conditions. Seminars in musculoskeletal radiology, 2014, Volume: 18, Issue:2 Topics: Adult; Biopsy; Bone Neoplasms; Chondrosarcoma; Fasciitis; Female; Fibrosarcoma; Fibrous Dysplasia of Bone; Fluorodeoxyglucose F18; Histiocytoma, Benign Fibrous; Humans; Lymphoma; Multiple Myeloma; Musculoskeletal Diseases; Neoplasm Staging; Osteosarcoma; Paraproteinemias; Plasmacytoma; Positron-Emission Tomography; Tomography, X-Ray Computed	2014
¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders. Clinical and experimental medicine, 2015, Volume: 15, Issue:1 Topics: Bone and Bones; Bone Marrow; Bone Neoplasms; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Plasmacytoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
State of the art imaging of multiple myeloma: comparative review of FDG PET/CT imaging in various clinical settings. European journal of radiology, 2014, Volume: 83, Issue:12 Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Multiple Myeloma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2014
Multiple myeloma: 18F-FDG-PET/CT and diagnostic imaging. Seminars in nuclear medicine, 2015, Volume: 45, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome	2015
A systematic review of MRI, scintigraphy, FDG-PET and PET/CT for diagnosis of multiple myeloma related bone disease--which is best? Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:22 Topics: Area Under Curve; Bone Diseases; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Meta-Analysis as Topic; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed	2014
Multiple myeloma. PET clinics, 2015, Volume: 10, Issue:2 Topics: Aged; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Neoplasm Metastasis; Neoplasm Staging; Paraproteinemias; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
State-of-the-art of bone marrow imaging in multiple myeloma. Current opinion in oncology, 2015, Volume: 27, Issue:6 Topics: Bone Marrow; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients. International journal of molecular sciences, 2017, Feb-18, Volume: 18, Issue:2 Topics: Bone Diseases; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Treatment Outcome	2017
Imaging in multiple myeloma. European journal of radiology, 2009, Volume: 70, Issue:3 Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Whole Body Imaging	2009
Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma. Annals of hematology, 2009, Volume: 88, Issue:12 Topics: Aged; Contrast Media; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Multiple Myeloma; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; X-Rays	2009
Assessing extracranial tumors using diffusion-weighted whole-body MRI. Zeitschrift fur medizinische Physik, 2011, Volume: 21, Issue:2 Topics: Adenoma, Liver Cell; Blood Glucose; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver Neoplasms; Lung Neoplasms; Male; Multiple Myeloma; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging	2011
Advances in imaging and the management of myeloma bone disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, May-10, Volume: 29, Issue:14 Topics: Bone Diseases; Diphosphonates; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Positron-Emission Tomography; Tomography, X-Ray Computed	2011
Imaging in multiple myeloma. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 2011, Volume: 183 Topics: Bone Marrow; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Neoplasm Staging; Plasmacytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2011
¹⁸F-fluoro-deoxyglucose positron emission tomography in assessment of myeloma-related bone disease: a systematic review. Cancer, 2012, Apr-15, Volume: 118, Issue:8 Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Whole-Body Irradiation	2012
Hematopoietic tumors and metastases involving bone. Radiologic clinics of North America, 2011, Volume: 49, Issue:6 Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Hematologic Neoplasms; Histiocytosis, Langerhans-Cell; Humans; Leukemia; Lymphoma; Magnetic Resonance Imaging; Multiple Myeloma; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging	2011
FDG PET or PET/CT for detecting intramedullary and extramedullary lesions in multiple Myeloma: a systematic review and meta-analysis. Clinical nuclear medicine, 2012, Volume: 37, Issue:9 Topics: Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Quality Control; Tomography, X-Ray Computed	2012
Is fluorine-18-fluorodeoxyglucose positron emission tomography useful in monitoring the response to treatment in patients with multiple myeloma? International journal of hematology, 2012, Volume: 96, Issue:6 Topics: Aged; Bone Marrow; Bone Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Disease-Free Survival; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Meta-Analysis as Topic; Middle Aged; Multimodal Imaging; Multiple Myeloma; Neoplasm Staging; Plasmacytoma; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome	2012
Myeloma update. Seminars in musculoskeletal radiology, 2007, Volume: 11, Issue:3 Topics: Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging	2007
A case of duodenal involvement of multiple myeloma imaged by positron emission tomography with 18F-fluorodeoxyglucose. The Tokai journal of experimental and clinical medicine, 2001, Volume: 26, Issue:4-6 Topics: Duodenal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multiple Myeloma; Neoplasms, Second Primary; Plasmacytoma; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography	2001

Trials

18 trial(s) available for fluorodeoxyglucose f18 and Multiple Myeloma

Article	Year
Visual and volumetric parameters by 18F-FDG-PET/CT: a head to head comparison for the prediction of outcome in patients with multiple myeloma. Annals of hematology, 2020, Volume: 99, Issue:1 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tomography, X-Ray Computed	2020
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Prospective Evaluation of Magnetic Resonance Imaging and [ Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, Sep-01, Volume: 35, Issue:25 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Stem Cell Transplantation; Survival Rate	2017
Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe). European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:5 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Italy; Male; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed	2018
Is there any complimentary role of F-18 NaF PET/CT in detecting of osseous involvement of multiple myeloma? A comparative study for F-18 FDG PET/CT and F-18 FDG NaF PET/CT. Annals of hematology, 2015, Volume: 94, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Fractures, Bone; Humans; Male; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
Baseline bone involvement in multiple myeloma - a prospective comparison of conventional X-ray, low-dose computed tomography, and 18flourodeoxyglucose positron emission tomography in previously untreated patients. Haematologica, 2016, Volume: 101, Issue:10 Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed	2016
F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma. Blood, 2009, Sep-03, Volume: 114, Issue:10 Topics: Aged; Aged, 80 and over; beta 2-Microglobulin; Bone Neoplasms; C-Reactive Protein; Cell Proliferation; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; L-Lactate Dehydrogenase; Male; Multiple Myeloma; Neoplasm Metastasis; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Risk Factors; Survival Rate	2009
Prediction of progression-free survival in patients with multiple myeloma following anthracycline-based chemotherapy based on dynamic FDG-PET. Clinical nuclear medicine, 2009, Volume: 34, Issue:9 Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Discriminant Analysis; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Multiple Myeloma; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Risk; Survival Analysis; Time Factors	2009
F-18 FDG uptake of bone marrow on PET/CT scan: it's correlation with CD38/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma. Annals of hematology, 2011, Volume: 90, Issue:1 Topics: ADP-ribosyl Cyclase 1; Adult; Aged; Aged, 80 and over; Bone Marrow; Bone Marrow Cells; Cell Count; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Syndecan-1; Tissue Distribution; Tomography, Emission-Computed	2011
Value of 18F-fluorodeoxyglucose uptake in positron emission tomography/computed tomography in predicting survival in multiple myeloma. European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Prognosis; Survival Analysis; Tomography, X-Ray Computed	2011
Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation. Blood, 2011, Dec-01, Volume: 118, Issue:23 Topics: Adult; Aged; Aged, 80 and over; Dexamethasone; Fluorodeoxyglucose F18; Glucocorticoids; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Middle Aged; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Thalidomide; Tomography, X-Ray Computed; Transplantation, Autologous	2011
¹⁸F-FAMT in patients with multiple myeloma: clinical utility compared to ¹⁸F-FDG. Annals of nuclear medicine, 2012, Volume: 26, Issue:10 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Methyltyrosines; Middle Aged; Multiple Myeloma; Positron-Emission Tomography	2012
Is FDG PET a better imaging tool than somatostatin receptor scintigraphy in patients with relapsing multiple myeloma? Clinical nuclear medicine, 2012, Volume: 37, Issue:10 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Radiography; Radionuclide Imaging; Receptors, Somatostatin; Recurrence	2012
The value of 18F-FDG PET/CT after autologous stem cell transplantation (ASCT) in patients affected by multiple myeloma (MM): experience with 77 patients. Clinical nuclear medicine, 2013, Volume: 38, Issue:2 Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Prognosis; Stem Cell Transplantation; Tomography, X-Ray Computed; Transplantation, Autologous	2013
Diagnosis of infection of implantable central venous catheters by [18F]fluorodeoxyglucose positron emission tomography. Nuclear medicine communications, 2004, Volume: 25, Issue:8 Topics: Adult; Antineoplastic Agents; Catheterization, Central Venous; Cross Infection; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Pilot Projects; Positron-Emission Tomography; Prosthesis-Related Infections; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thrombophlebitis	2004
Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results. European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:5 Topics: Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Pilot Projects; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed	2006
Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis. Annals of hematology, 2007, Volume: 86, Issue:6 Topics: Aged; Diphosphonates; Fluorodeoxyglucose F18; Humans; Jaw Diseases; Multiple Myeloma; Osteonecrosis; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi	2007
Initial results in the assessment of multiple myeloma using 18F-FDG PET. European journal of nuclear medicine and molecular imaging, 2002, Volume: 29, Issue:3 Topics: Adult; Aged; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed	2002

Other Studies

199 other study(ies) available for fluorodeoxyglucose f18 and Multiple Myeloma

Article	Year
[Metabolic imaging in lymphoid hemopathies]. La Revue du praticien, 2021, Volume: 71, Issue:5 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Multiple Myeloma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals	2021
Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On Clinical lymphoma, myeloma & leukemia, 2022, Volume: 22, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Stem Cell Transplantation; Transplantation, Autologous	2022
Anti-BCMA Immuno-NanoPET Radiotracers for Improved Detection of Multiple Myeloma. Advanced healthcare materials, 2022, Volume: 11, Issue:2 Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Positron-Emission Tomography; Radioisotopes	2022
Editorial Comment: FDG PET/CT Has the Edge Over Whole-Body MRI in the Evaluation of Multiple Myeloma Treatment Response, for Now. AJR. American journal of roentgenology, 2022, Volume: 218, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2022
Pancreatic involvement in a patient with multiple myeloma revealed by [ Revista espanola de medicina nuclear e imagen molecular, 2022, Volume: 41 Suppl 1 Topics: Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2022
Optimization of whole-body 2-[ European radiology, 2022, Volume: 32, Issue:5 Topics: Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging	2022
Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status. Haematologica, 2021, 12-01, Volume: 106, Issue:12 Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2021
Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and Blood cancer journal, 2021, 12-01, Volume: 11, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Risk Assessment	2021
Rare Distribution of Sclerotic Bony Lesions in Multiple Myeloma: A Case Report. Clinical nuclear medicine, 2022, Apr-01, Volume: 47, Issue:4 Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Multiple Myeloma; Plasmacytoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2022
68Ga-Pentixafor PET/CT Improves the Detection of Recurrent Myeloma in the Temporal Bone Masked by the Physiological 18F-FDG Uptake of the Brain and Extraocular Muscles. Clinical nuclear medicine, 2022, Apr-01, Volume: 47, Issue:4 Topics: Aged; Brain; Coordination Complexes; Female; Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Oculomotor Muscles; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Temporal Bone	2022
Molecular Signature of Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2022, Volume: 63, Issue:7 Topics: Biomarkers; Fluorodeoxyglucose F18; Gene Expression Profiling; Humans; Multiple Myeloma; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2022
Amyloid Arthropathy and Pseudomyopathy Associated With Multiple Myeloma Detected by 18F-Florapronol Amyloid PET/CT. Clinical nuclear medicine, 2022, Apr-01, Volume: 47, Issue:4 Topics: Amyloidosis; Fluorodeoxyglucose F18; Humans; Joint Diseases; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed	2022
[Value of Zhongguo shi yan xue ye xue za zhi, 2022, Volume: 30, Issue:1 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies	2022
Secondary Gastrointestinal Amyloidosis With Increased 18 F-FDG Uptake as the Only Presentation in a Patient With Multiple Myeloma. Clinical nuclear medicine, 2022, Aug-01, Volume: 47, Issue:8 Topics: Amyloidosis; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed	2022
Utility of PET/CT in assessing early treatment response in patients with newly diagnosed multiple myeloma. Blood advances, 2022, 05-10, Volume: 6, Issue:9 Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies	2022
18F-FDG-PET/CT in relapsed multiple myeloma: Are prognostic thresholds different from first-line therapy? BMC medical imaging, 2022, 04-04, Volume: 22, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies	2022
Differential Performances in Lesions and Radiotracer of Current medical imaging, 2023, Volume: 19, Issue:7 Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2023
A Rare Extramedullary Involvement Site in Patients With Multiple Myeloma: Stomach. Clinical nuclear medicine, 2022, 11-01, Volume: 47, Issue:11 Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Stomach	2022
Skin Involvement in Multiple Myeloma Demonstrated on FDG PET/CT. Revista espanola de medicina nuclear e imagen molecular, 2022, Volume: 41 Suppl 1 Topics: Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2022
Radiological outcome of bone disease in multiple myeloma patients pre- and post therapy: A single center experience. Saudi medical journal, 2022, Volume: 43, Issue:8 Topics: Bone Diseases; Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies	2022
Relation of whole-body metabolic tumor volume and total lesion glycolysis on fluorodeoxyglucose PET/computed tomography with clinical and laboratory parameters in newly diagnosed multiple myeloma. Nuclear medicine communications, 2022, Oct-01, Volume: 43, Issue:10 Topics: Biomarkers; Fluorodeoxyglucose F18; Glycolysis; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden	2022
Bone marrow segmentation and radiomics analysis of [ Computer methods and programs in biomedicine, 2022, Volume: 225 Topics: Bone Marrow; Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2022
Prevalence and clinical impact of incidental findings on the unenhanced CT images of PET/CT scan in patients with multiple myeloma: the value of radiological reporting in the multimodal hybrid imaging. European review for medical and pharmacological sciences, 2022, Volume: 26, Issue:16 Topics: Aged; Fluorodeoxyglucose F18; Humans; Incidental Findings; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2022
[18F-fluorodesoxyglucose positron emission tomography/computed tomography in extramedullary multiple myeloma]. Revista medica de Chile, 2022, Volume: 150, Issue:2 Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2022
Prognostic value of positron emission tomography/computed tomography in transplant-eligible newly diagnosed multiple myeloma patients from CASSIOPEIA: the CASSIOPET study. Haematologica, 2023, 02-01, Volume: 108, Issue:2 Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals	2023
[Malignant paraganglioma mimicking multiple myeloma]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2022, Volume: 63, Issue:10 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Hypercalcemia; Multiple Myeloma; Paraganglioma; Positron Emission Tomography Computed Tomography	2022
Imaging minimal residual disease evaluation in multiple myeloma using [ Leukemia & lymphoma, 2023, Volume: 64, Issue:2 Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2023
Unusual Extramedullary Manifestation in Multiple Myeloma: Bilateral Synchronous Testicular Infiltration. Clinical nuclear medicine, 2023, Feb-01, Volume: 48, Issue:2 Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Multiple Myeloma; Orchiectomy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2023
In vivo British journal of haematology, 2023, Volume: 200, Issue:6 Topics: Bone Neoplasms; Fluorides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Osteogenesis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2023
Bilateral breast multiple myeloma: a case report. Hong Kong medical journal = Xianggang yi xue za zhi, 2022, Volume: 28, Issue:6 Topics: Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammography; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals	2022
A prognostication system based on clinical parameters and [ European journal of nuclear medicine and molecular imaging, 2023, Volume: 50, Issue:6 Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies	2023
Hypermetabolic Subserosal Uterine Leiomyoma With Synchronous Atypical Multiple Myeloma Mimicking Ovarian Malignancy With Multiple Bone Metastases on 18F-FDG PET/CT. Clinical nuclear medicine, 2023, Feb-01, Volume: 48, Issue:2 Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Middle Aged; Multiple Myeloma; Myoma; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Uterine Neoplasms	2023
2-[ 18 F]FDG PET/CT Flare-up Phenomena Following T-Cell Engager Bispecific Antibody in Multiple Myeloma. Clinical nuclear medicine, 2023, May-01, Volume: 48, Issue:5 Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2023
Cluster analysis of autoencoder-extracted FDG PET/CT features identifies multiple myeloma patients with poor prognosis. Scientific reports, 2023, 05-15, Volume: 13, Issue:1 Topics: Artificial Intelligence; Cluster Analysis; Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden	2023
How do we image patients with multiple myeloma and precursor states? British journal of haematology, 2023, Volume: 203, Issue:4 Topics: Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Whole Body Imaging	2023
Dual assessment with multiparameter flow cytometry and Bone marrow transplantation, 2023, Volume: 58, Issue:9 Topics: Flow Cytometry; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals	2023
BMC medical imaging, 2023, 06-27, Volume: 23, Issue:1 Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Likelihood Functions; Machine Learning; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Prognosis	2023
Semi-quantitative FDG parameters predict survival in multiple myeloma patients without autologous stem cell transplantation. Cancer imaging : the official publication of the International Cancer Imaging Society, 2023, Oct-27, Volume: 23, Issue:1 Topics: Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Transplantation, Autologous; Tumor Burden	2023
Multiple myeloma mimicking primary bone tumour. BMJ case reports, 2019, 10-08, Volume: 12, Issue:10 Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bortezomib; Cyclophosphamide; Dexamethasone; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Male; Multiple Myeloma; Neoplasms, Multiple Primary; Osteolysis; Plasma Cells; Positron-Emission Tomography	2019
MRI versus European radiology, 2020, Volume: 30, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies	2020
Cardiac tamponade in multiple myeloma - A pictorial case review of FDG PET/CT findings. Journal of medical imaging and radiation oncology, 2020, Volume: 64, Issue:3 Topics: Aged; Cardiac Tamponade; Fluorodeoxyglucose F18; Humans; Male; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2020
Brain glucose metabolism in patients with newly diagnosed multiple myeloma significantly decreases after high-dose chemotherapy followed by autologous stem cell transplantation. Nuclear medicine communications, 2020, Volume: 41, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Brain; Brain Chemistry; Cerebellum; Combined Modality Therapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multiple Myeloma; Observer Variation; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Stem Cell Transplantation; Supratentorial Neoplasms; Transplantation, Autologous	2020
Computed tomography-based skeletal segmentation for quantitative PET metrics of bone involvement in multiple myeloma. Nuclear medicine communications, 2020, Volume: 41, Issue:4 Topics: Bone and Bones; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Whole Body Imaging	2020
18F-FDG PET/CT Findings in a Patient With Neutrophilic Leukemoid Reaction Associated With Multiple Myeloma. Clinical nuclear medicine, 2020, Volume: 45, Issue:5 Topics: Female; Fluorodeoxyglucose F18; Humans; Leukemoid Reaction; Middle Aged; Multiple Myeloma; Plasmacytoma; Positron Emission Tomography Computed Tomography	2020
A Rare Extramedullary Presentation of Multiple Myeloma: Paraspinal Muscle Involvement Revealed by FDG PET/CT Turkish journal of haematology : official journal of Turkish Society of Haematology, 2021, Feb-25, Volume: 38, Issue:1 Topics: Biopsy; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Middle Aged; Multiple Myeloma; Paraspinal Muscles; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed	2021
FDG PET/CT Imaging of Pancreatic Plasmacytoma. Clinical nuclear medicine, 2020, Volume: 45, Issue:6 Topics: Biopsy; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Pancreatic Neoplasms; Plasmacytoma; Positron Emission Tomography Computed Tomography	2020
Diagnostic relevance of 18F-FDG PET/CT in newly diagnosed patients with monoclonal gammopathy of undetermined significance (MGUS): Single-center experience. Neoplasma, 2020, Volume: 67, Issue:4 Topics: Adult; Fluorodeoxyglucose F18; Humans; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2020
[PET/CT with 18F-fluorodeoxyglucose and 11C-methionine after autologous stem cell transplantation in multiple myeloma patients]. Terapevticheskii arkhiv, 2019, Jul-15, Volume: 91, Issue:7 Topics: Carbon Radioisotopes; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Methionine; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Transplantation, Autologous	2019
Marrow uptake on FDG PET/CT is associated with progression from smoldering to symptomatic multiple myeloma. Skeletal radiology, 2021, Volume: 50, Issue:1 Topics: Bone Marrow; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies	2021
Extramedullary Myeloma of the Uterus on 18F-FDG PET/CT: A Rare Manifestation of Multiple Myeloma. Clinical nuclear medicine, 2020, Volume: 45, Issue:11 Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Uterus	2020
99mTc-sestamibi SPECT/CT and 18F-FDG-PET/CT have similar performance but different imaging patterns in newly diagnosed multiple myeloma. Nuclear medicine communications, 2020, Volume: 41, Issue:10 Topics: Adult; Aged; Biological Transport; Diffusion; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Technetium Tc 99m Sestamibi	2020
Rare Extramedullary Cardiac Involvement of Recurrent Multiple Myeloma Suspected on 18F-FDG and Confirmed on 18F-Fluorocholine. Clinical nuclear medicine, 2020, Volume: 45, Issue:11 Topics: Biopsy; Choline; Fluorodeoxyglucose F18; Heart; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography	2020
Evaluation of Sarcopenia with F-18 FDG PET/CT and relation with disease outcomes in patients with multiple myeloma. European journal of cancer care, 2020, Volume: 29, Issue:6 Topics: Female; Fluorodeoxyglucose F18; Humans; Infant, Newborn; Male; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcopenia; Tomography, X-Ray Computed	2020
Asymptomatic COVID-19 Infection Detected on 18F-FDG PET/CT Scan Done for Multiple Myeloma. Clinical nuclear medicine, 2021, Volume: 46, Issue:1 Topics: Aged; Asymptomatic Diseases; COVID-19; Female; Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography	2021
Diagnostic performance of British journal of haematology, 2021, Volume: 193, Issue:1 Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Osteolysis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiography; Reproducibility of Results; Sensitivity and Specificity; Smoldering Multiple Myeloma	2021
Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two independent prospective European trials. European journal of nuclear medicine and molecular imaging, 2021, Volume: 48, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals	2021
Concurrent Liver and Mesentery Primary Extraosseous Multiple Myeloma on 18F-FDG PET/CT. Clinical nuclear medicine, 2021, Feb-01, Volume: 46, Issue:2 Topics: Aged; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Mesentery; Middle Aged; Multiple Myeloma; Neoplasms, Multiple Primary; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography	2021
A proposed index of diffuse bone marrow [18F]-FDG uptake and PET skeletal patterns correlate with myeloma prognostic markers, plasma cell morphology, and response to therapy. European journal of nuclear medicine and molecular imaging, 2021, Volume: 48, Issue:5 Topics: Bone Marrow; Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Plasma Cells; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies	2021
Critical role of PET/CT-based novel quantitative techniques for assessing global disease activity in multiple myeloma and other hematological malignancies: why it is time to abandon reliance on examining focal lesions. European radiology, 2021, Volume: 31, Issue:1 Topics: Fluorodeoxyglucose F18; Hematologic Neoplasms; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2021
Standardization of Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021, 01-10, Volume: 39, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Clinical Trials, Phase III as Topic; Dexamethasone; Female; Fluorodeoxyglucose F18; Humans; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Stem Cell Transplantation	2021
First Experience of Turkish journal of haematology : official journal of Turkish Society of Haematology, 2022, 02-23, Volume: 39, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Methionine; Multiple Myeloma; Positron-Emission Tomography; Turkey	2022
Virtual calcium-suppression in dual energy computed tomography predicts metabolic activity of focal MM lesions as determined by fluorodeoxyglucose positron-emission-tomography. European journal of radiology, 2021, Volume: 135 Topics: Calcium; Electrons; Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Reproducibility of Results; Tomography, X-Ray Computed	2021
(18)F-sodium fluoride PET in multiple myeloma: Linking cancer to atherosclerosis? Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2021, Volume: 28, Issue:6 Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron-Emission Tomography; Sodium Fluoride	2021
Comparison of the diagnostic performance and impact on management of 18F-FDG PET/CT and whole-body MRI in multiple myeloma. European journal of nuclear medicine and molecular imaging, 2021, Volume: 48, Issue:8 Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging	2021
Prognostic impact of International journal of hematology, 2021, Volume: 113, Issue:5 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Prognosis; Renal Insufficiency; Retrospective Studies	2021
Total diffusion volume in MRI vs. total lesion glycolysis in PET/CT for tumor volume evaluation of multiple myeloma. European radiology, 2021, Volume: 31, Issue:8 Topics: Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Glycolysis; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden	2021
F-18 FDG PET/CT and F-18 FLT PET/CT as predictors of outcome in patients with multiple myeloma. A pilot study. European journal of radiology, 2021, Volume: 136 Topics: Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Pilot Projects; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2021
Agreement Between 18F-FDG PET/CT and Whole-Body Magnetic Resonance Compared With Skeletal Survey for Initial Staging and Response at End-of-Treatment Evaluation of Patients With Multiple Myeloma. Clinical nuclear medicine, 2021, 04-01, Volume: 46, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Retrospective Studies; Skeleton; Treatment Outcome; Whole Body Imaging	2021
Adipose tissue radiodensity: A new prognostic biomarker in people with multiple myeloma. Nutrition (Burbank, Los Angeles County, Calif.), 2021, Volume: 86 Topics: Adipose Tissue; Biomarkers; Fluorodeoxyglucose F18; Humans; Intra-Abdominal Fat; Multiple Myeloma; Prognosis	2021
Multiple Myeloma Presenting as Disseminated Osteoblastic Lesions With Intense 18F-FDG Uptake on PET/CT. Clinical nuclear medicine, 2021, Oct-01, Volume: 46, Issue:10 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals	2021
Visceral adipose tissue glucose uptake is linked to prognosis in multiple myeloma patients: An exploratory study. Clinical nutrition (Edinburgh, Scotland), 2021, Volume: 40, Issue:6 Topics: Aged; Anthropometry; Body Composition; Female; Fluorodeoxyglucose F18; Glucose; Humans; Intra-Abdominal Fat; Male; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies	2021
Resting-state brain metabolic fingerprinting clusters (biomarkers) and predictive models for major depression in multiple myeloma patients. PloS one, 2021, Volume: 16, Issue:5 Topics: Biomarkers; Brain; Brain Mapping; Case-Control Studies; Depressive Disorder, Major; Female; Fluorodeoxyglucose F18; Humans; Machine Learning; Male; Middle Aged; Multiple Myeloma; Neuroimaging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies	2021
Prognostic Impact of Metabolic Heterogeneity in Patients With Newly Diagnosed Multiple Myeloma Using 18F-FDG PET/CT. Clinical nuclear medicine, 2021, Oct-01, Volume: 46, Issue:10 Topics: Fluorodeoxyglucose F18; Glycolysis; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Tumor Burden	2021
Prognostic impact of posttransplant FDG PET/CT scan in multiple myeloma. Blood advances, 2021, 07-13, Volume: 5, Issue:13 Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies	2021
Prediction of Long Bone Fractures in Multiple Myeloma Patients in an Advanced Imaging World. The Israel Medical Association journal : IMAJ, 2021, Volume: 23, Issue:8 Topics: Biopsy; Bone Marrow; Cortical Bone; Female; Femoral Fractures; Fluorodeoxyglucose F18; Fracture Fixation; Humans; Humeral Fractures; Israel; Male; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Assessment	2021
Bone marrow tracer uptake pattern of PET-CT in multiple myeloma: image interpretation and prognostic value. Annals of hematology, 2021, Volume: 100, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Prognosis	2021
Adult B-Cell Acute Lymphoblastic Leukemia Dominated by Osteolytic Bone Involvement on CT But Less Impressive PET on FDG PET/CT Images. Clinical nuclear medicine, 2017, Volume: 42, Issue:6 Topics: Biological Transport; Biopsy; Fluorodeoxyglucose F18; Humans; Leukemia, B-Cell; Male; Middle Aged; Multiple Myeloma; Osteolysis; Positron Emission Tomography Computed Tomography	2017
Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma. Blood, 2017, 07-06, Volume: 130, Issue:1 Topics: False Positive Reactions; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Hexokinase; Humans; Male; Multiple Myeloma; Neoplasm Proteins; Positron-Emission Tomography	2017
Neuro-Myelomatosis of the Brachial Plexus - An Unusual Site of Disease Visualized by FDG-PET/CT: A Case Report. The American journal of case reports, 2017, May-01, Volume: 18 Topics: Brachial Plexus; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multiple Myeloma; Peripheral Nervous System Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2017
Impressive Paget Disease of the Lumbar Spine Masks the Coexisting Multiple Myeloma. Clinical nuclear medicine, 2017, Volume: 42, Issue:9 Topics: False Negative Reactions; Fluorodeoxyglucose F18; Humans; Lumbar Vertebrae; Male; Middle Aged; Multiple Myeloma; Osteitis Deformans; Positron Emission Tomography Computed Tomography	2017
Guidelines for the use of imaging in the management of patients with myeloma. British journal of haematology, 2017, Volume: 178, Issue:3 Topics: Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Plasmacytoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Cord Compression; Spinal Fractures; Tomography, X-Ray Computed; Treatment Outcome	2017
Paraneoplastic Sarcoidosis in Multiple Myeloma. Internal medicine (Tokyo, Japan), 2017, Volume: 56, Issue:15 Topics: Aged; Biopsy; Bone Diseases; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Mediastinum; Multiple Myeloma; Paraneoplastic Syndromes; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed	2017
Predictive value of European journal of haematology, 2018, Volume: 100, Issue:2 Topics: Adult; Aged; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Male; Middle Aged; Multiple Myeloma; Multivariate Analysis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; ROC Curve; Symptom Assessment	2018
Treatment to suppression of focal lesions on positron emission tomography-computed tomography is a therapeutic goal in newly diagnosed multiple myeloma. Haematologica, 2018, Volume: 103, Issue:6 Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Prognosis; Survival Analysis; Treatment Outcome	2018
Added prognostic value of FDG-PET/CT in relapsing multiple myeloma patients. Leukemia & lymphoma, 2019, Volume: 60, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Stem Cell Transplantation; Transplantation, Autologous	2019
Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma Turkish journal of haematology : official journal of Turkish Society of Haematology, 2018, 08-03, Volume: 35, Issue:3 Topics: ADP-ribosyl Cyclase 1; Adult; Aged; Aged, 80 and over; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Male; Membrane Glycoproteins; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Syndecan-1	2018
FDG PET-CT in Adrenal Multiple Myeloma. Clinical nuclear medicine, 2018, Volume: 43, Issue:9 Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Multiple Myeloma; Positron Emission Tomography Computed Tomography	2018
Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation. European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:1 Topics: Aged; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Male; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Transplantation, Autologous; Treatment Outcome	2019
Interim PET Analysis in First-Line Therapy of Multiple Myeloma: Prognostic Value of ΔSUVmax in the FDG-Avid Patients of the IMAJEM Study. Clinical cancer research : an official journal of the American Association for Cancer Research, 2018, 11-01, Volume: 24, Issue:21 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Multiple Myeloma; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Treatment Outcome	2018
Central Nervous System Myelomatosis Delineated by High-Resolution Brain Images From Fully Digital 18F-FDG PET. Clinical nuclear medicine, 2018, Volume: 43, Issue:10 Topics: Brain; Central Nervous System Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Sensitivity and Specificity	2018
The Role of Contrast media & molecular imaging, 2018, Volume: 2018 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Multivariate Analysis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Survival Analysis	2018
Utility and prognostic value of American journal of hematology, 2018, Volume: 93, Issue:12 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Survival Analysis	2018
Skeletal Superscan on 18F-FDG PET/CT in a Patient With Multiple Myeloma. Clinical nuclear medicine, 2019, Volume: 44, Issue:2 Topics: Bone and Bones; Bone Marrow; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography	2019
[PRT/CT with (18)F-FDG or (11)C-methionine for multiple myeloma]. Nihon rinsho. Japanese journal of clinical medicine, 2016, Volume: 74 Suppl 5 Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron-Emission Tomography; Tomography, X-Ray Computed	2016
Pretreatment European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:6 Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Multivariate Analysis; Neoplasm Staging; Plasma Cells; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Whole Body Imaging	2019
Multiple Myeloma of Testes and Spermatic Cord on 18F-FDG PET/CT. Clinical nuclear medicine, 2019, Volume: 44, Issue:4 Topics: Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Male; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Prognosis; Spermatic Cord; Testis	2019
Quantitative dynamic Haematologica, 2019, Volume: 104, Issue:9 Topics: Adult; Aged; Clinical Trials, Phase III as Topic; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Kinetics; Male; Middle Aged; Multiple Myeloma; Phosphorylation; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Prospective Studies; Randomized Controlled Trials as Topic; Reference Values; Transplantation, Autologous; Whole Body Imaging	2019
European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:5 Topics: Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies	2019
Low hexokinase-2 expression-associated false-negative European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:6 Topics: Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; False Negative Reactions; Female; Fluorodeoxyglucose F18; Hexokinase; Humans; Male; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome	2019
Correlation Between Uptake of Technology in cancer research & treatment, 2019, 01-01, Volume: 18 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Male; Middle Aged; Multiple Myeloma; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Survival Analysis; Treatment Outcome	2019
The Finding of the "Mini Brain" May Not Be a Unique Anatomic Appearance of Spinal Plasmacytoma. Clinical nuclear medicine, 2019, Volume: 44, Issue:7 Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Giant Cell Tumors; Humans; Male; Multiple Myeloma; Plasmacytoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Spinal Cord Neoplasms	2019
Imaging Characteristics of Coexisting Primary Pulmonary Carcinoid Tumor and Multiple Myeloma on 18F-FDG and 68Ga-DOTATATE PET/CT. Clinical nuclear medicine, 2019, Volume: 44, Issue:11 Topics: Aged; Biopsy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multiple Myeloma; Neoplasm Grading; Neoplasms, Multiple Primary; Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography	2019
Diffuse Infiltration of Multiple Myeloma With Initial Manifestation of Cavernous Sinus Syndrome Unveiled by 18F-FDG PET/CT. Clinical nuclear medicine, 2019, Volume: 44, Issue:9 Topics: Biopsy; Cavernous Sinus; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography	2019
Multiple myeloma presenting as plasmacytoma of the jaws showing prominent bone formation during chemotherapy. Dento maxillo facial radiology, 2013, Volume: 42, Issue:4 Topics: Aged; Angiogenesis Inhibitors; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Contrast Media; Cyclophosphamide; Dexamethasone; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Mandibular Condyle; Mandibular Neoplasms; Multimodal Imaging; Multiple Myeloma; Osteogenesis; Plasmacytoma; Positron-Emission Tomography; Radiography, Panoramic; Radiopharmaceuticals; Remission Induction; Thalidomide; Tomography, X-Ray Computed	2013
Retroperitoneal plasmacytoma. The Journal of urology, 2013, Volume: 190, Issue:1 Topics: Aged, 80 and over; Biopsy, Needle; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Multimodal Imaging; Multiple Myeloma; Neoplasm Invasiveness; Neoplasm Staging; Plasmacytoma; Positron-Emission Tomography; Prognosis; Radiographic Image Enhancement; Retroperitoneal Neoplasms; Tomography, X-Ray Computed	2013
False-positive PET scan after bone marrow biopsy. British journal of haematology, 2013, Volume: 161, Issue:6 Topics: Aged; Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Humans; Male; Multiple Myeloma; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed	2013
Whole-body MRI and PET/CT in multiple myeloma patients during staging and after treatment: personal experience in a longitudinal study. La Radiologia medica, 2013, Volume: 118, Issue:6 Topics: Aftercare; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging	2013
Different lesions revealed by 18F-FDG PET/CT and 18F-NaF PET/CT in patients with multiple myeloma. Clinical nuclear medicine, 2014, Volume: 39, Issue:9 Topics: Aged, 80 and over; Bone and Bones; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride; Tomography, X-Ray Computed	2014
Positive correlation between baseline PET or PET/CT findings and clinical parameters in multiple myeloma patients. Acta haematologica, 2014, Volume: 131, Issue:4 Topics: Academic Medical Centers; Adult; Biomarkers; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Republic of Korea; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed	2014
Targeting paraprotein biosynthesis for non-invasive characterization of myeloma biology. PloS one, 2013, Volume: 8, Issue:12 Topics: Cell Line, Tumor; Flow Cytometry; Fluorodeoxyglucose F18; Humans; Methionine; Multiple Myeloma; Paraproteins; Positron-Emission Tomography; Radioactive Tracers; Statistics, Nonparametric; Tyrosine	2013
Clinical contribution of PET/CT in myeloma: from the perspective of a radiologist. Clinical lymphoma, myeloma & leukemia, 2014, Volume: 14, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron-Emission Tomography; Radiology; Radiopharmaceuticals	2014
Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myeloma. Clinical lymphoma, myeloma & leukemia, 2014, Volume: 14, Issue:3 Topics: Aged; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Male; Multiple Myeloma; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed	2014
PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF: comparison of distribution patterns and tracers' pharmacokinetics. European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:7 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Pelvis; Positron-Emission Tomography; Radioactive Tracers; Sodium Fluoride; Tomography, X-Ray Computed; Whole Body Imaging	2014
Analysis of thymidine kinase serum levels by novel method DiviTum in multiple myeloma and monoclonal gammopathy of undetermined significance - comparison with imaging methods 99mTc-MIBI scintigraphy and 18F-FDG PET/CT. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 2015, Volume: 159, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Positron-Emission Tomography; Prognosis; Prohibitins; Radioimmunoassay; Radiopharmaceuticals; Thymidine Kinase; Tomography, X-Ray Computed	2015
11C-acetate PET/CT for metabolic characterization of multiple myeloma: a comparative study with 18F-FDG PET/CT. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:5 Topics: Acetates; Adult; Aged; Aged, 80 and over; Carbon; Case-Control Studies; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lipid Metabolism; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Paraproteinemias; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Risk; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden	2014
Impact of initial FDG-PET/CT and serum-free light chain on transformation of conventionally defined solitary plasmacytoma to multiple myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Jun-15, Volume: 20, Issue:12 Topics: Aged; Biomarkers, Tumor; Bone Neoplasms; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunoglobulin Light Chains; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Plasmacytoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed	2014
FDG PET/CT depicts cutaneous plasmocytoma. Clinical nuclear medicine, 2014, Volume: 39, Issue:10 Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Neoplasm Invasiveness; Plasmacytoma; Positron-Emission Tomography; Radiopharmaceuticals; Skin; Tomography, X-Ray Computed	2014
[PET-CT for nuclear medicine diagnostics of multiple myeloma]. Der Radiologe, 2014, Volume: 54, Issue:6 Topics: Fluorodeoxyglucose F18; Humans; Molecular Imaging; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2014
Bilateral renal infiltration as the initial presentation of multiple myeloma. British journal of haematology, 2014, Volume: 167, Issue:1 Topics: Aged; Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Kidney; Magnetic Resonance Imaging; Multiple Myeloma; Positron-Emission Tomography	2014
18 FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation. Oncotarget, 2014, Sep-15, Volume: 5, Issue:17 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Stem Cell Transplantation; Tomography, X-Ray Computed	2014
Comparison of (11)C-4'-thiothymidine, (11)C-methionine, and (18)F-FDG PET/CT for the detection of active lesions of multiple myeloma. Annals of nuclear medicine, 2015, Volume: 29, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Carbon Radioisotopes; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Methionine; Middle Aged; Multimodal Imaging; Multiple Myeloma; Plasmacytoma; Positron-Emission Tomography; Radiopharmaceuticals; Thionucleosides; Thymidine; Tomography, X-Ray Computed; Whole Body Imaging	2015
18F-FDG PET increases visibility of bone lesions in relapsed multiple myeloma: is this hypoxia-driven? Clinical nuclear medicine, 2015, Volume: 40, Issue:4 Topics: Basic Helix-Loop-Helix Transcription Factors; Bone Marrow; Bone Neoplasms; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Middle Aged; Multiple Myeloma; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals; Vascular Endothelial Growth Factor A	2015
18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study. Clinical nuclear medicine, 2015, Volume: 40, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Survival Analysis; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed	2015
[Clinical value of 18F-FDG-PET and 11C-MET-PET in patients with plasma cell malignancy]. Nihon rinsho. Japanese journal of clinical medicine, 2015, Volume: 73, Issue:1 Topics: Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Plasma Cells; Positron-Emission Tomography; Radiopharmaceuticals	2015
The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015, Volume: 21, Issue:6 Topics: Adult; Aged; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Graft Survival; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Male; Middle Aged; Multiple Myeloma; Myeloablative Agonists; Positron-Emission Tomography; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Siblings; Survival Analysis; Tomography, X-Ray Computed; Transplantation Conditioning; Transplantation, Homologous; Unrelated Donors	2015
(18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate. Clinical nuclear medicine, 2015, Volume: 40, Issue:6 Topics: Aged; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Neoplasm Invasiveness; Plasma Cells; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
Pseudomyogenic Hemangioendothelioma Mimicking Multiple Myeloma on 18F-FDG PET/CT, Followed by Spontaneous Regression. Clinical nuclear medicine, 2015, Volume: 40, Issue:7 Topics: Diagnostic Errors; Fluorodeoxyglucose F18; Hemangioendothelioma; Humans; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2015, Oct-01, Volume: 21, Issue:19 Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; In Situ Hybridization, Fluorescence; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Young Adult	2015
18F-FDG and 18F-NaF PET/CT Findings of a Multiple Myeloma Patient With Thyroid Cartilage Involvement. Clinical nuclear medicine, 2015, Volume: 40, Issue:11 Topics: Adult; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride; Thyroid Cartilage; Thyroid Neoplasms; Tomography, X-Ray Computed	2015
Role of FDG-PET/CT in Extramedullary Multiple Myeloma: Correlation of FDG-PET/CT Findings With Clinical Outcome. Clinical nuclear medicine, 2016, Volume: 41, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed	2016
[Diagnostic Value of (18)F-FDG-PET/CT for Multiple Myeloma]. Zhongguo shi yan xue ye xue za zhi, 2015, Volume: 23, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Tomography, X-Ray Computed	2015
Mass-forming extramedullary hematopoiesis in multiple myeloma: 18F-FDG PET/CT is useful in excluding extramedullary myeloma involvement. Tumori, 2016, Nov-11, Volume: 102, Issue:Suppl. 2 Topics: Biomarkers; Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Hematopoiesis, Extramedullary; Humans; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Radiographic Image Enhancement; Thalidomide	2016
Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe). European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:3 Topics: Adult; Aged; Fluorodeoxyglucose F18; Fractures, Bone; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Italy; Middle Aged; Multimodal Imaging; Multiple Myeloma; Neoplasm Staging; Nuclear Medicine; Observer Variation; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Tomography, X-Ray Computed	2016
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease. Leukemia, 2016, Volume: 30, Issue:2 Topics: Aged; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Osteolysis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed	2016
18F-FDG PET/CT Demonstrated the Multiple Myeloma From Prostate. Clinical nuclear medicine, 2016, Volume: 41, Issue:4 Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Multiple Myeloma; Plasmacytoma; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed	2016
First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016, Volume: 57, Issue:2 Topics: Aged; Antineoplastic Agents; Bone Marrow Transplantation; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Metastasis; Peptides; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Receptors, CXCR4; Treatment Outcome	2016
Bone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: a prospective study using functional and morphologic imaging. Leukemia & lymphoma, 2016, Volume: 57, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone and Bones; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Precancerous Conditions	2016
11C-Methionine-PET in Multiple Myeloma: Correlation with Clinical Parameters and Bone Marrow Involvement. Theranostics, 2016, Volume: 6, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Male; Methionine; Middle Aged; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2016
New Perspectives Offered by Nuclear Medicine for the Imaging and Therapy of Multiple Myeloma. Theranostics, 2016, Volume: 6, Issue:2 Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Nuclear Medicine; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2016
18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study. European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:11 Topics: Aged; Aged, 80 and over; Choline; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Pilot Projects; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Sensitivity and Specificity	2016
Whole-body 18F-FDG PET/CT in patients with multiple myeloma. Medicina clinica, 2017, 04-07, Volume: 148, Issue:7 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2017
Evaluating Acetate Metabolism for Imaging and Targeting in Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2017, Jan-15, Volume: 23, Issue:2 Topics: Acetates; Animals; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lipid Metabolism; Magnetic Resonance Imaging; Mice; Multiple Myeloma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tissue Distribution	2017
Application of PET/CT in treatment response evaluation and recurrence prediction in patients with newly-diagnosed multiple myeloma. Oncotarget, 2017, Apr-11, Volume: 8, Issue:15 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytogenetic Analysis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Mutation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Recurrence; ROC Curve; Tomography, X-Ray Computed; Treatment Outcome	2017
Gastrointestinal histoplasmosis in a patient after autologous stem cell transplant for multiple myeloma. Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:6 Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; beta-Glucans; Colonoscopy; Fever; Fluorodeoxyglucose F18; Gastrointestinal Diseases; Hematopoietic Stem Cell Transplantation; Histoplasma; Histoplasmosis; Humans; Ileum; Intestinal Obstruction; Itraconazole; Lymphadenopathy; Male; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Weight Loss	2016
The role of 68Ga-DOTA-TATE PET/CT scanning in the evaluation of patients with multiple myeloma: preliminary results. Nuclear medicine communications, 2017, Volume: 38, Issue:1 Topics: Adult; Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Middle Aged; Multiple Myeloma; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals	2017
Improved Detection of Minimal Residual Disease by 11C-Methionine PET/CT in a Young Patient With Unusual Extramedullary Presentation of Recurrent Multiple Myeloma. Clinical nuclear medicine, 2017, Volume: 42, Issue:2 Topics: Adult; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Humans; Methionine; Multiple Myeloma; Muscle Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2017
18F-FDG super bone marrow uptake: A highly potent indicator for the malignant infiltration. Medicine, 2016, Volume: 95, Issue:52 Topics: Adolescent; Adult; Aged; Bone Marrow; Bone Neoplasms; C-Reactive Protein; Child; Female; Fever; Fluorodeoxyglucose F18; Hemoglobins; Humans; L-Lactate Dehydrogenase; Leukemia; Leukocyte Count; Lymphoma; Male; Middle Aged; Multiple Myeloma; Platelet Count; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Young Adult	2016
Muscle Involvement of Multiple Myeloma Revealed by FDG PET/CT. Clinical nuclear medicine, 2017, Volume: 42, Issue:4 Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Multiple Myeloma; Muscle, Skeletal; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2017
Primary cutaneous plasmacytoma. International journal of hematology, 2017, Volume: 105, Issue:5 Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bortezomib; Cell Transformation, Neoplastic; Cyclophosphamide; Dexamethasone; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gene Rearrangement; Humans; Immunoglobulin Heavy Chains; Immunoglobulin M; Middle Aged; Multiple Myeloma; Plasma Cells; Positron-Emission Tomography; Proto-Oncogene Proteins c-bcl-6; Radiopharmaceuticals; Skin Neoplasms; Treatment Outcome	2017
Modern imaging of multiple myeloma. Acta radiologica (Stockholm, Sweden : 1987), 2008, Volume: 49, Issue:5 Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2008
Value of precise localization of recurrent multiple myeloma with F-18 FDG PET/CT. Clinical nuclear medicine, 2009, Volume: 34, Issue:1 Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Multiple Myeloma; Positron-Emission Tomography; Recurrence; Sensitivity and Specificity; Tomography, X-Ray Computed	2009
(18)F-Fluorodeoxyglucose avid liver lesion in a patient with multiple myeloma. European journal of haematology, 2009, Volume: 83, Issue:2 Topics: Fluorodeoxyglucose F18; Humans; Liver; Male; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Tomography, X-Ray Computed	2009
Whole-Body MRI versus PET in assessment of multiple myeloma disease activity. AJR. American journal of roentgenology, 2009, Volume: 192, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Whole Body Imaging	2009
The prognostic value of F-18 fluorodeoxyglucose bone marrow uptake in patients with recent diagnosis of multiple myeloma: a comparative study with Tc-99m sestamibi. Clinical nuclear medicine, 2010, Volume: 35, Issue:1 Topics: Aged; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multiple Myeloma; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi	2010
Current concepts in the evaluation of multiple myeloma with MR imaging and FDG PET/CT. Radiographics : a review publication of the Radiological Society of North America, Inc, 2010, Volume: 30, Issue:1 Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed	2010
F-18 FDG PET/CT imaging of multifocal extramedullary pancreatic myeloma. Clinical nuclear medicine, 2010, Volume: 35, Issue:3 Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed	2010
(11)C-Methionine PET/CT for multiple myeloma. International journal of hematology, 2010, Volume: 91, Issue:5 Topics: Female; Fluorodeoxyglucose F18; Humans; Immunoglobulin A; Methionine; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Whole Body Imaging	2010
FDG PET/CT manifestations of hematopoietic malignancies of the breast. Academic radiology, 2010, Volume: 17, Issue:8 Topics: Adult; Breast Neoplasms; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Hematologic Neoplasms; Humans; Leukemia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Plasmacytoma; Positron-Emission Tomography; Tomography, X-Ray Computed	2010
[18F-FDG PET/CT and 99mTc-MIBI scintigraphy in evaluation of patients with multiple myeloma and monoclonal gammopathy of unknown significance: comparison of methods]. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2010, Volume: 23, Issue:5 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed	2010
Combining FDG-PET/CT with laboratory data yields superior results for prediction of relapse in multiple myeloma. European journal of haematology, 2011, Volume: 86, Issue:4 Topics: Adult; Aged; beta 2-Microglobulin; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multiple Myeloma; Myeloma Proteins; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2011
The value of FDG PET/CT in the initial staging and bone marrow involvement of patients with multiple myeloma. Skeletal radiology, 2011, Volume: 40, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult	2011
Characterizing and predicting pathologic spine fractures in myeloma patients with FDG PET/CT and MR imaging. Cancer investigation, 2011, Volume: 29, Issue:5 Topics: Acute Disease; Adult; Aged; Baltimore; Chronic Disease; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Plasmacytoma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Spinal Fractures; Spine; Tomography, X-Ray Computed	2011
Immunoglobulin D-lambda type multiple myeloma presenting with FDG-PET/CT negative bone marrow involvement. Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:14 Topics: Aged; Bone Marrow; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Immunoglobulin D; Magnetic Resonance Imaging; Male; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Plasmacytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2011
Lesions of multiple myeloma adjacent to the skull are better visualized on F-18 fluoroethyldimethyl-2-hydroxyethylammonium (FECH) PET images than on F-18 FDG PET images. Clinical nuclear medicine, 2011, Volume: 36, Issue:10 Topics: Choline; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Quaternary Ammonium Compounds; Skull; Tomography, X-Ray Computed	2011
18F-FDG PET to identify soft tissue disease in multiple myeloma. European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:3 Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Soft Tissue Neoplasms	2012
Atypical presentation of plasma cell leukemia secondary to multiple myeloma detected by F-18 FDG PET/CT. Clinical nuclear medicine, 2011, Volume: 36, Issue:12 Topics: Female; Fluorodeoxyglucose F18; Humans; Leukemia, Plasma Cell; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging	2011
18F-FDG PET/CT for detection and localization of residual or recurrent disease in patients with multiple myeloma after stem cell transplantation. European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:3 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Neoplasm, Residual; Positron-Emission Tomography; Recurrence; Reference Standards; Reproducibility of Results; Retrospective Studies; Stem Cell Transplantation; Tomography, X-Ray Computed; Transplantation, Autologous; Transplantation, Homologous	2012
PET-CT in MM: a new definition of CR. Blood, 2011, Dec-01, Volume: 118, Issue:23 Topics: Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Tomography, X-Ray Computed	2011
Comparative diagnostic performance of ¹⁸F-FDG PET/CT versus whole-body MRI for determination of remission status in multiple myeloma after stem cell transplantation. European radiology, 2013, Volume: 23, Issue:2 Topics: Adult; Aged; Cohort Studies; Confidence Intervals; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Graft Survival; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Neoplasm Staging; Positron-Emission Tomography; Postoperative Care; Predictive Value of Tests; Stem Cell Transplantation; Survival Analysis; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2013
Contrast enhanced MRI and ¹⁸F-FDG PET-CT in the assessment of multiple myeloma: a comparison of results in different phases of the disease. European journal of radiology, 2012, Volume: 81, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Disease Progression; Female; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed	2012
Metabolic tumor volume assessed by 18F-FDG PET/CT for the prediction of outcome in patients with multiple myeloma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden	2012
[Clinical diagnostic imaging (including FDG-PET/CT)]. Nihon rinsho. Japanese journal of clinical medicine, 2012, Volume: 70 Suppl 2 Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Multiple Myeloma; Positron-Emission Tomography; Tomography, X-Ray Computed	2012
FDG-PET in the evaluation of myeloma in 2012. Diagnostic and interventional imaging, 2013, Volume: 94, Issue:2 Topics: Bone Marrow; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Plasmacytoma; Positron-Emission Tomography; Sensitivity and Specificity	2013
Current role of CT and whole body MRI in multiple myeloma. Diagnostic and interventional imaging, 2013, Volume: 94, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Radiation Dosage; Retrospective Studies; Tomography, X-Ray Computed; Whole Body Imaging	2013
Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3. Blood, 2013, Mar-07, Volume: 121, Issue:10 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Clinical Trials as Topic; Fluorodeoxyglucose F18; Follow-Up Studies; Gene Expression Profiling; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate	2013
Multiple myeloma imaging. Diagnostic and interventional imaging, 2013, Volume: 94, Issue:2 Topics: Bone and Bones; Fluorodeoxyglucose F18; France; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Tomography, X-Ray Computed	2013
Whole-body (18)F-FDG PET identifies high-risk myeloma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Paraproteinemias; Plasmacytoma; Prognosis; Radiopharmaceuticals; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon	2002
Diagnostic utility of FDG PET in multiple myeloma. Skeletal radiology, 2002, Volume: 31, Issue:12 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Radiopharmaceuticals; Tomography, Emission-Computed	2002
2-[18] fluoro-2-deoxy-D-glucose positron emission tomography imaging in non-secretory multiple myeloma. British journal of haematology, 2003, Volume: 123, Issue:4 Topics: Femur; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Radiopharmaceuticals; Tomography, Emission-Computed	2003
F-18 fluorodeoxyglucose positron emission tomographic imaging in a patient with persistent hiccups. Clinical nuclear medicine, 2004, Volume: 29, Issue:1 Topics: Baclofen; Brain; Brain Neoplasms; Chlorpromazine; Diagnosis, Differential; Fluorodeoxyglucose F18; Hiccup; Humans; Magnetic Resonance Imaging; Male; Multiple Myeloma; Muscle Relaxants, Central; Nifedipine; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Failure	2004
A comparison of fluorine-18 fluoro-deoxyglucose PET and technetium-99m sestamibi in assessing patients with multiple myeloma. European journal of haematology, 2004, Volume: 72, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Fluorodeoxyglucose F18; Humans; Middle Aged; Multiple Myeloma; Neoplasm Staging; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Retrospective Studies; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed	2004
DKK1 in multiple myeloma. The New England journal of medicine, 2004, Apr-01, Volume: 350, Issue:14 Topics: Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Intercellular Signaling Peptides and Proteins; Multiple Myeloma; Oligonucleotide Array Sequence Analysis; Osteolysis; Proteins; Tomography, Emission-Computed	2004
Value of FDG PET in the assessment of patients with multiple myeloma. AJR. American journal of roentgenology, 2005, Volume: 184, Issue:4 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	2005
18F-fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: a study of 165 infectious episodes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Nov-01, Volume: 23, Issue:31 Topics: Adult; Aged; Anti-Bacterial Agents; Female; Fluorodeoxyglucose F18; Humans; Joint Diseases; Male; Medical Records; Middle Aged; Multiple Myeloma; Radiopharmaceuticals; Retrospective Studies; Soft Tissue Infections; Time Factors; Tomography, Emission-Computed	2005
[PET--options and limitations]. Vnitrni lekarstvi, 2006, Volume: 52, Issue:3 Topics: Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2006
[The value of fluorodeoxyglucose positron emission tomography in multiple myeloma]. Vnitrni lekarstvi, 2006, Volume: 52, Issue:3 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Paraproteinemias; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction	2006
Comparison of imaging with FDG PET/CT with other imaging modalities in myeloma. Skeletal radiology, 2006, Volume: 35, Issue:9 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed	2006
A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. Haematologica, 2007, Volume: 92, Issue:1 Topics: Adult; Aged; Bone Marrow Transplantation; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Prospective Studies; Whole Body Imaging	2007
Guidelines for the use of imaging in the management of myeloma. British journal of haematology, 2007, Volume: 137, Issue:1 Topics: Bone and Bones; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed; Whole-Body Counting	2007
11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma. World journal of surgical oncology, 2007, Jun-20, Volume: 5 Topics: Bone and Bones; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2007
F-18 FDG PET/CT staging of multiple myeloma with diffuse osseous and extramedullary lesions. Clinical nuclear medicine, 2007, Volume: 32, Issue:10 Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms; Subtraction Technique; Tomography, X-Ray Computed	2007
Fluorodeoxyglucose positron emission tomography in multiple myeloma, solitary plasmocytoma and monoclonal gammapathy of unknown significance. Neoplasma, 2007, Volume: 54, Issue:6 Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Neoplasm Staging; Paraproteinemias; Plasmacytoma; Positron-Emission Tomography; Tomography, Emission-Computed	2007
Multiple myeloma presenting with [18F]fluorodeoxyglucose avid liver lesions diagnosed on positron emission tomography scan. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Nov-20, Volume: 25, Issue:33 Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Liver; Multiple Myeloma; Positron-Emission Tomography	2007
18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:2 Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed	2008
Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw. Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Apr-15, Volume: 14, Issue:8 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Remodeling; Diphosphonates; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Humans; Jaw Diseases; Male; Middle Aged; Multiple Myeloma; Osteogenesis; Osteonecrosis; Positron-Emission Tomography	2008
Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma. Acta radiologica (Stockholm, Sweden : 1987), 2008, Volume: 49, Issue:4 Topics: Aged; Algorithms; Bone Marrow; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Spinal Neoplasms	2008
Fluorine-18-fluorodeoxyglucose positron emission tomography in technetium-99m-hydroxymethylenediphosphate negative bone tumors. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1993, Volume: 34, Issue:2 Topics: Adult; Bone Neoplasms; Deoxyglucose; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Ribs; Technetium Tc 99m Medronate; Tomography, Emission-Computed	1993
Technetium-99m-MIBI versus fluorine-18-FDG in diffuse multiple myeloma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997, Volume: 38, Issue:8 Topics: Aged; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Multiple Myeloma; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed	1997
Fluoro-deoxyglucose positron emission tomography imaging for the detection of occult disease in multiple myeloma. British journal of haematology, 2002, Volume: 117, Issue:1 Topics: Adult; Bone and Bones; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Tomography, Emission-Computed	2002